JP2016506412A5 - - Google Patents

Download PDF

Info

Publication number
JP2016506412A5
JP2016506412A5 JP2015549900A JP2015549900A JP2016506412A5 JP 2016506412 A5 JP2016506412 A5 JP 2016506412A5 JP 2015549900 A JP2015549900 A JP 2015549900A JP 2015549900 A JP2015549900 A JP 2015549900A JP 2016506412 A5 JP2016506412 A5 JP 2016506412A5
Authority
JP
Japan
Prior art keywords
cancer
flightless
subject
level
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015549900A
Other languages
English (en)
Japanese (ja)
Other versions
JP6487849B2 (ja
JP2016506412A (ja
Filing date
Publication date
Priority claimed from AU2013202668A external-priority patent/AU2013202668B2/en
Application filed filed Critical
Publication of JP2016506412A publication Critical patent/JP2016506412A/ja
Publication of JP2016506412A5 publication Critical patent/JP2016506412A5/ja
Application granted granted Critical
Publication of JP6487849B2 publication Critical patent/JP6487849B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015549900A 2012-12-24 2013-12-20 癌の増殖及び転移の阻害 Expired - Fee Related JP6487849B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AU2012905692 2012-12-24
AU2012905692A AU2012905692A0 (en) 2012-12-24 Inhibition of cancer growth and metastasis
AU2013202668 2013-04-05
AU2013202668A AU2013202668B2 (en) 2012-12-24 2013-04-05 Inhibition of cancer growth and metastasis
PCT/AU2013/001498 WO2014100852A1 (en) 2012-12-24 2013-12-20 Inhibition of cancer growth and metastasis

Publications (3)

Publication Number Publication Date
JP2016506412A JP2016506412A (ja) 2016-03-03
JP2016506412A5 true JP2016506412A5 (https=) 2017-02-16
JP6487849B2 JP6487849B2 (ja) 2019-03-20

Family

ID=51019569

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015549900A Expired - Fee Related JP6487849B2 (ja) 2012-12-24 2013-12-20 癌の増殖及び転移の阻害

Country Status (6)

Country Link
US (2) US9895414B2 (https=)
EP (1) EP2934499A4 (https=)
JP (1) JP6487849B2 (https=)
AU (1) AU2013202668B2 (https=)
CA (1) CA2896261A1 (https=)
WO (1) WO2014100852A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016040987A1 (en) * 2014-09-15 2016-03-24 Abregen Pty Ltd Treating and/or preventing psoriasis
CN108137660B (zh) * 2014-10-07 2021-06-01 印度科学工业研究所 用于纯化和定量凝溶胶蛋白及其变体的适体
CN105132357B (zh) * 2015-07-29 2019-12-06 苏州诺普再生医学有限公司 一种用于表皮细胞培养的无血清培养体系
US11236337B2 (en) 2016-11-01 2022-02-01 The Research Foundation For The State University Of New York 5-halouracil-modified microRNAs and their use in the treatment of cancer
WO2020077397A1 (en) * 2018-10-15 2020-04-23 Abregen Pty Ltd Methods and compositions for the treatment of mucosal lesions
WO2021262919A2 (en) 2020-06-26 2021-12-30 The Research Foundation For The State University Of New York 5-halouracil-modified micrornas and their use in the treatment of cancer

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US4987071A (en) 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
US5258498A (en) 1987-05-21 1993-11-02 Creative Biomolecules, Inc. Polypeptide linkers for production of biosynthetic proteins
EP0436597B1 (en) 1988-09-02 1997-04-02 Protein Engineering Corporation Generation and selection of recombinant varied binding proteins
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
SE462454B (sv) 1988-11-10 1990-06-25 Pharmacia Ab Maetyta foer anvaendning i biosensorer
AU7247191A (en) 1990-01-11 1991-08-05 Molecular Affinities Corporation Production of antibodies using gene libraries
US5780225A (en) 1990-01-12 1998-07-14 Stratagene Method for generating libaries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
US5698426A (en) 1990-09-28 1997-12-16 Ixsys, Incorporated Surface expression libraries of heteromeric receptors
CA2095633C (en) 1990-12-03 2003-02-04 Lisa J. Garrard Enrichment method for variant proteins with altered binding properties
ATE414768T1 (de) 1991-04-10 2008-12-15 Scripps Research Inst Bibliotheken heterodimerer rezeptoren mittels phagemiden
PT1024191E (pt) 1991-12-02 2008-12-22 Medical Res Council Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos
US5733743A (en) 1992-03-24 1998-03-31 Cambridge Antibody Technology Limited Methods for producing members of specific binding pairs
EP0700521B1 (en) 1993-05-28 2003-06-04 Baylor College Of Medicine Method and mass spectrometer for desorption and ionization of analytes
WO1995015982A2 (en) 1993-12-08 1995-06-15 Genzyme Corporation Process for generating specific antibodies
DE69534347T2 (de) 1994-01-31 2006-05-24 Trustees Of Boston University, Boston Bibliotheken aus Polyklonalen Antikörpern
US5516637A (en) 1994-06-10 1996-05-14 Dade International Inc. Method involving display of protein binding pairs on the surface of bacterial pili and bacteriophage
JP2978435B2 (ja) 1996-01-24 1999-11-15 チッソ株式会社 アクリロキシプロピルシランの製造方法
NZ516848A (en) 1997-06-20 2004-03-26 Ciphergen Biosystems Inc Retentate chromatography apparatus with applications in biology and medicine
US6251588B1 (en) 1998-02-10 2001-06-26 Agilent Technologies, Inc. Method for evaluating oligonucleotide probe sequences
CA2323638A1 (en) 1998-04-03 1999-10-14 Phylos, Inc. Addressable protein arrays
US6406921B1 (en) 1998-07-14 2002-06-18 Zyomyx, Incorporated Protein arrays for high-throughput screening
WO2000056934A1 (en) 1999-03-24 2000-09-28 Packard Bioscience Company Continuous porous matrix arrays
EP1456668B1 (en) 2001-12-05 2007-05-02 Sense Proteomic Limited Protein arrays for allelic variants and uses thereof
AU2002359791A1 (en) 2001-12-21 2003-07-30 Diadexus, Inc. Compositions and methods relating to urinary specific genes and proteins
US7276381B2 (en) 2002-01-25 2007-10-02 Bio-Rad Laboratories, Inc. Monomers and polymers having energy absorbing moieties of use in desorption/ionization of analytes
US20050260639A1 (en) 2002-09-30 2005-11-24 Oncotherapy Science, Inc. Method for diagnosing pancreatic cancer
JP5153639B2 (ja) 2005-10-25 2013-02-27 ウィミンズ アンド チルドレンズ ヘルス リサーチ インスティテュート 創傷修復を調節するための方法及び組成物
US20070248628A1 (en) * 2005-12-06 2007-10-25 Keller Lorraine H Immunogens in cancer stem cells
EP2012127A3 (en) 2007-07-03 2009-03-11 Koninklijke Philips Electronics N.V. Diagnostic markers for detecting prostate cancer
US20090098535A1 (en) * 2007-07-31 2009-04-16 Institut Pasteur Upregulation of rack-1 in melanoma and its use as a marker
AU2011229130A1 (en) 2010-03-17 2012-11-01 Adelaide Research & Innovation Pty Ltd A sensor and a method for characterising a dielectric material

Similar Documents

Publication Publication Date Title
Kok et al. Cancer-derived exosomes: their role in cancer biology and biomarker development
Loboda et al. A gene expression signature of RAS pathway dependence predicts response to PI3K and RAS pathway inhibitors and expands the population of RAS pathway activated tumors
Yuan et al. MiR‐940 inhibits hepatocellular carcinoma growth and correlates with prognosis of hepatocellular carcinoma patients
Liu et al. LincRNA FEZF1-AS1 represses p21 expression to promote gastric cancer proliferation through LSD1-mediated H3K4me2 demethylation
JP2016506412A5 (https=)
Ng et al. Clinical relevance and therapeutic potential of angiopoietin-like protein 4 in hepatocellular carcinoma
Liu et al. MiR-29c suppresses invasion and metastasis by targeting TIAM1 in nasopharyngeal carcinoma
CN106456694B (zh) 与循环肿瘤细胞相关的方法和测定法
Hailer et al. Loss of tumor suppressor mir-203 mediates overexpression of LIM and SH3 Protein 1 (LASP1) in high-risk prostate cancer thereby increasing cell proliferation and migration
Dai et al. Characterization of the oncogenic function of centromere protein F in hepatocellular carcinoma
CN102421919B (zh) 采用Axl作为上皮‑间质转化的生物标志物的方法
ES2877757T3 (es) Tratamiento terapéutico de cáncer de mama basado en el estado de c-MAF
JP2015521050A5 (https=)
JP2007506426A5 (https=)
US10526656B2 (en) Methods of diagnosing chronic obstructive pulmonary disease (COPD) using novel molecular biomarkers
US20200017914A1 (en) Methods of diagnosing chronic obstructive pulmonary disease (copd) using novel molecular biomarkers
WO2006024283A3 (de) Verbindungen und methoden zur behandlung, diagnose und prognose bei pankreaserkrankungen
Ennen et al. DDB2: a novel regulator of NF-κB and breast tumor invasion
JP6110346B2 (ja) miR−31に関連する組成物および方法
Yan et al. Downregulation of RPL15 may predict poor survival and associate with tumor progression in pancreatic ductal adenocarcinoma
Liu et al. Role of circular RNAs in cancer therapy resistance
JP2017525337A5 (https=)
Bukhari et al. PINTology: A short history of the lncRNA LINC‐PINT in different diseases
US20170335393A1 (en) Methods of diagnosing chronic obstructive pulmonary disease (copd) using novel molecular biomarkers
JP2020500502A5 (https=)